Literature DB >> 29448120

Imaging features of malignant abdominal neuroendocrine tumors with rare presentation.

Giuseppe Corrias1, Serena Monti2, Natally Horvat3, Laura Tang4, Olca Basturk5, Luca Saba6, Lorenzo Mannelli7.   

Abstract

BACKGROUND: Gastroenteropancreatic neuroendocrine tumors (NETs) are rare entities arising from neuroendocrine cells in the gastroenteric tract and pancreas. The purpose of this article is to present four cases of gastroenteropancreatic NETs that featured a challenging diagnosis. CASE
PRESENTATION: We report a case series of four NETs, each with different features. All NETs were suspected based on clinical and biochemical data. The workup of the abnormalities was performed with CT, PET or MRI.
CONCLUSION: The diagnosis of NETs is challenging and generally based on clinical manifestations, blood biochemical tests, imaging techniques, and pathology.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biliary neuroendocrine tumor; Glucagonoma; Insulinoma; MRI; Neuroendocrine tumors; Octreoscan

Mesh:

Year:  2018        PMID: 29448120      PMCID: PMC6082726          DOI: 10.1016/j.clinimag.2018.02.004

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  33 in total

Review 1.  Uncommon pancreatic tumors and pseudotumors.

Authors:  Neeraj Lalwani; Lorenzo Mannelli; Dhakshina Moorthy Ganeshan; Alampady K Shanbhogue; Manjiri K Dighe; Hina Arif Tiwari; Suresh Maximin; Serena Monti; Monica Ragucci; Srinivasa R Prasad
Journal:  Abdom Imaging       Date:  2015-01

2.  A pregnant patient with hypoglycemia.

Authors:  Lorenzo Mannelli; Matthew M Yeh; Carolyn L Wang
Journal:  Gastroenterology       Date:  2012-08-23       Impact factor: 22.682

3.  Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades.

Authors:  E Belousova; G Karmazanovsky; A Kriger; D Kalinin; L Mannelli; A Glotov; N Karelskaya; O Paklina; A Kaldarov
Journal:  Clin Radiol       Date:  2016-11-24       Impact factor: 2.350

Review 4.  Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature.

Authors:  M Fraenkel; M Kim; A Faggiano; W W de Herder; G D Valk
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

5.  Midgut carcinoid tumors: CT findings and biochemical profiles.

Authors:  P K Woodard; J M Feldman; S S Paine; M E Baker
Journal:  J Comput Assist Tomogr       Date:  1995 May-Jun       Impact factor: 1.826

6.  Multidetector CT enteroclysis versus barium enteroclysis with methylcellulose in patients with suspected small bowel disease.

Authors:  Laura Maria Minordi; Amorino Vecchioli; Luisa Guidi; Paoletta Mirk; Luisa Fiorentini; Lorenzo Bonomo
Journal:  Eur Radiol       Date:  2006-03-22       Impact factor: 5.315

7.  Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management.

Authors:  Dushyant V Sahani; Pietro A Bonaffini; Carlos Fernández-Del Castillo; Michael A Blake
Journal:  Radiology       Date:  2013-01       Impact factor: 11.105

8.  Biomarkers in neuroendocrine tumors.

Authors:  Marvin Duque; Irvin M Modlin; Anumeha Gupta; Muhammad Wasif Saif
Journal:  JOP       Date:  2013-07-10

9.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).

Authors:  John K Ramage; A Ahmed; J Ardill; N Bax; D J Breen; M E Caplin; P Corrie; J Davar; A H Davies; V Lewington; T Meyer; J Newell-Price; G Poston; N Reed; A Rockall; W Steward; R V Thakker; C Toubanakis; J Valle; C Verbeke; A B Grossman
Journal:  Gut       Date:  2011-11-03       Impact factor: 23.059

10.  Glucagonoma and Glucagonoma Syndrome: A Case Report with Review of Recent Advances in Management.

Authors:  Ashraf Al-Faouri; Khaled Ajarma; Samer Alghazawi; Sura Al-Rawabdeh; Adnan Zayadeen
Journal:  Case Rep Surg       Date:  2016-02-14
View more
  4 in total

1.  Fast non-enhanced abdominal examination protocols in PET/MRI for patients with neuroendocrine tumors (NET): comparison to multiphase contrast-enhanced PET/CT.

Authors:  Ferdinand Seith; Christina Schraml; Gerald Reischl; Konstantin Nikolaou; Christina Pfannenberg; Christian la Fougère; Nina Schwenzer
Journal:  Radiol Med       Date:  2018-06-30       Impact factor: 3.469

2.  CT- and ultrasound-characteristics of hepatic lesions in patients with multiple endocrine neoplasia syndrome. A retrospective image review of 25 cases.

Authors:  Nassim Fard; Heinz-Peter Schlemmer; Friedhelm Raue; Björn Jobke
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

3.  Dynamic Enhancement Pattern on CT for Predicting Pancreatic Neuroendocrine Neoplasms with Low PAX6 Expression: A Retrospective Observational Study.

Authors:  Koichiro Kimura; Junichi Tsuchiya; Yoshio Kitazume; Mitsuhiro Kishino; Keiichi Akahoshi; Atsushi Kudo; Shinji Tanaka; Minoru Tanabe; Ukihide Tateishi
Journal:  Diagnostics (Basel)       Date:  2020-11-09

4.  The impact of 18F-FDOPA-PET/MRI image fusion in detecting liver metastasis in patients with neuroendocrine tumors of the gastrointestinal tract.

Authors:  O Barachini; R Bernt; S Mirzaei; C Pirich; K Hergan; S Zandieh
Journal:  BMC Med Imaging       Date:  2020-02-24       Impact factor: 1.930

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.